CIK 0001566044
- Non-accelerated filer
- Smaller reporting company
Yarrow Bioscience, Inc.
Sign in to watch- Ticker
- YARW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453757789
- Phone
- +1 203-433-7577
- Business address
- 470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 2 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-11 | Krasnow Ronald A. | Shares withheld for taxes | −8,271 | $4.52 | $37K | 15,819 |
| 2019-12-11 | Krasnow Ronald A. | Exercise or conversion · Restricted Stock Units | −24,090 | 0 | ||
| 2019-12-11 | BALL KRISTINE M | Exercise or conversion | +80,300 | 80,300 | ||
| 2019-12-11 | BALL KRISTINE M | Shares withheld for taxes | −27,766 | $4.52 | $126K | 52,534 |
| 2019-12-11 | Basta Steven L Chief Executive Officer | Exercise or conversion | +238,800 | 580,974 | ||
| 2019-12-11 | Basta Steven L Chief Executive Officer | Shares withheld for taxes | −85,210 | $4.52 | $385K | 495,764 |
| 2019-12-11 | Basta Steven L Chief Executive Officer | Exercise or conversion | +14,000 | $1.83 | $26K | 509,764 |
| 2019-12-11 | Basta Steven L Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −238,800 | 0 | ||
| 2019-12-11 | Basta Steven L Chief Executive Officer | Exercise or conversion · Non-Qualified Stock Option | −14,000 | $1.83 | $26K | 357,641 |
| 2019-07-29 | Basta Steven L Chief Executive Officer | Grant or award · Restricted Stock Units | +238,800 | 1,050,100 | ||
| 2019-07-29 | Kwon Paul Chief Scientific Officer | Grant or award · Restricted Stock Units | +80,300 | 396,812 | ||
| 2019-07-29 | BALL KRISTINE M | Grant or award · Restricted Stock Units | +80,300 | 413,423 | ||
| 2019-07-29 | Krasnow Ronald A. | Grant or award · Restricted Stock Units | +24,090 | 154,090 | ||
| 2019-07-29 | Basta Steven L Director | Grant or award · Restricted Stock Units | +238,800 | 1,050,100 | ||
| 2019-07-29 | BALL KRISTINE M | Grant or award · Restricted Stock Units | +80,300 | 413,423 | ||
| 2019-07-29 | Kwon Paul | Grant or award · Restricted Stock Units | +80,300 | 396,812 | ||
| 2019-06-25 | Ebel Ted Director | Grant or award · Stock Option | +22,500 | 53,423 | ||
| 2019-06-25 | Royston Aaron Director | Grant or award · Stock Option | +22,500 | 22,500 | ||
| 2019-06-25 | BERNS PAUL L Director | Grant or award · Stock Option | +22,500 | 65,780 | ||
| 2019-06-25 | Whitcup Scott M Director | Grant or award · Stock Option | +22,500 | 134,099 |
Page 18 of 22 · 425 trades